They are also known as bolus injectors or patch pumps.
Wearable injectors are used to subcutaneously administer insulin and other drugs that require large dose volumes and extended delivery period.
The increasing prevalence of various chronic diseases, rising concern for injuries caused due to needles and increasing demand for round the clock monitoring are expected to drive the growth of the market during the forecast period.
On the other hand, preference for traditional methods of drug administration and lack of skilled labor who can instruct patients about wearable injectors and its usage may hinder the growth of the market during the forecast period.
Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the assessment period owing to favorable government initiatives for the medical devices industry.
The market in the Middle East & Africa is likely to account for the smallest share of the global wearable injectors market.